期刊文献+

核转录因子FOXP3蛋白在人脑星形细胞肿瘤组织中的表达及临床意义 被引量:4

Clinical significance of immunohistochemically detecting forkhead box P3 expression in human astrocytic tumors
下载PDF
导出
摘要 目的:检测星形细胞肿瘤组织中FOXP3蛋白的表达,探讨星形细胞肿瘤组织中FOXP3的表达与临床病理特征以及预后的关系。方法:应用免疫组织化学技术检测121例星形细胞肿瘤和5例脑膜瘤,5例正常脑组织中FOXP3的表达。分析FOXP3的表达与星形细胞肿瘤各临床病理参数及预后的关系。结果:FOXP3蛋白在人脑星形细胞肿瘤组织中有表达,在脑膜瘤和正常脑组织中均未见表达,FOXP3蛋白主要表达于间质淋巴细胞的细胞核。在星形细胞肿瘤中,FOXP3的表达在各级别星形细胞肿瘤中表达差异显著(P<0.05)。Kaplan-Meier生存分析提示FOXP3阳性组和阴性组生存时间差异显著(P<0.01),但COX多因素变量分析结果显示,FOXP3不是影响星形细胞肿瘤患者术后生存时间的独立预后因素(P>0.05)。结论:FOXP3在星形细胞肿瘤间质淋巴细胞中的表达与星形细胞肿瘤的恶性程度以及病人的年龄相关。FOXP3阳性的星形细胞肿瘤的预后较FOXP3阴性的星形细胞肿瘤差,但不能作为影响星形细胞肿瘤生存时间的独立预后因素。FOXP3可能成为星形细胞肿瘤免疫调节的新靶点。 AIM: To investigate the expression of forkhead box p3(FOXP3) protein in astrocytic tumors,and analyze its clinical significance.METHODS: We measured the incidence of FOXP3 in 121 astrocytomas,5 meningiomas,5 normal brain tissues using immunohistochemistry,analyzed the correlation of the presence of FOXP3 with histopathologic features and survival.RESULTS: FOXP3 exists in human brain astrocytic tumors,which was not found in meningioma and normal brain tissues.FOXP3 was expressed in interstitial lymphocytes mainly,and expressed in tumor cells rarely.The differences on FOXP3 expression between all grade levels were statistically significant(P0.05).The Kaplan-Meier survival analysis showed that there was significant difference between the two survival curves,and the survival rate of the group with negative FOXP3 expression was higher than that of the positive group.Multivariate Cox proportional hazards regression analysis indicated that FOXP3 could not serve as an independent prognostic factor of astrocytic tumors survival time(P0.05).CONCLUSION: FOXP3 immunoreactivity is significantly associated with the age and the malignancy of human astrocytic tumors.Astrocytic tumor patients with FOXP3 expression have poorer prognosis,while FOXP3 can not serve as an independent prognostic factor of astrocytic tumors survival time.FOXP3 may provide a new target for immunotherapy of astrocytic tumors.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2010年第8期1479-1482,共4页 Chinese Journal of Pathophysiology
基金 广东省科技计划资助项目(No.20061040645) 广州市科技计划资助项目(No.2007Z3-E4061) 广东省自然科学基金资助项目(No.8151008901000012) 国家自然科学基金资助项目(No.30973080)
关键词 星形细胞瘤 蛋白质FOXP3 调节性T细胞 Astrocytoma Protein FOXP3 Regulatory T cells
  • 相关文献

参考文献17

  • 1Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3[J].Science,2003,299(5609):1057-1061.
  • 2Fontenot JD,Rasmussen JP,Williams LM,et al.Regulatory T cell lineage specification by the forkhead transcription factor foxp3[J].Immunity,2005,22(3):329-341.
  • 3陈莉娟,周浩,朱剑文,邹丽.Foxp3转染小鼠CD4^+CD25^-T细胞抑制NK细胞活性[J].中国病理生理杂志,2009,25(6):1151-1155. 被引量:6
  • 4Salama P,Phillips M,Grieu F,et al.Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer[J].J Clin Oncol,2009,27(2):186-192.
  • 5Curiel TJ,Coukos G,Zou L,et al.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival[J].Nat Med,2004,10(9):942-949.
  • 6Yuan XL,Chen L,Li MX,et al.Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner[J].Clin Immunol,2010,134(3):277-288.
  • 7Liyanage UK,Goedegebuure PS,Moore TY,et al.Increased prevalence of regulatory T cells(Treg)is induced by pancreas adenocarcinoma[J].J lmmunother,2006,29(4):416-424.
  • 8Merlo A,Casalini P,Careangiu ML,et al.FOXP3 expression and overall survival in breast cancer[J].J Clin Oncol,2009,27(11):1746-1752.
  • 9Ebert LM,Tan BS,Browning J,et al.The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells[J].Cancer Res,2008,68(8):3001-3009.
  • 10Karanikas V,Speletas M,Zamanakou M,et al.Foxp3 expression in human cancer cells[J].J Transl Med,2008,6:19.

二级参考文献30

  • 1吴正升,吴强,杨枫.乳腺癌组织明胶酶的表达及其与TGFβ1的关系[J].陕西医学杂志,2004,33(11):967-970. 被引量:2
  • 2曹新国,王礼文.人类免疫调控转录因子FOXP3研究进展[J].临床检验杂志,2006,24(1):63-65. 被引量:12
  • 3黄秀艳,曾耀英,肇静娴,王通.小鼠派氏集合淋巴结T细胞活化和调节性T细胞的分析[J].中国病理生理杂志,2006,22(3):537-542. 被引量:1
  • 4赵丽丽,曲迅,梁路,杨美香,孔北华,董白桦,吕晓梅,张友忠,白晓霞.妊娠子宫微环境中uNK细胞NKG2A和NKG2D及其配体表达的研究[J].中国病理生理杂志,2006,22(8):1636-1639. 被引量:4
  • 5Hori S, Nomura T, Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3 [ J ]. Science, 2003,299 (5609) :1057 - 1061.
  • 6Ebert L M,Tan B S, Browning J,et al. The regulatory T cell-associated transcription factor FOXP'3 is expressed by tumor cells [ J ]. Cancer Res,2008,68 (8) :3001 - 3009.
  • 7Hinz S, Pagerols-Raluy L, Oberg H H, et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer[ J]. Cancer Res ,2007,67 ( 17 ) :8344 - 8350.
  • 8Brunkow M E,Jeffery E W,Hjerrild K A ,et al. Disruption of a new forkhead/winged - helix protein, scurfin, results in the fatal lymphopruliferative disorder of the scurfy mouse [ J ]. Nat Genet,2001, 27(1) :68 -73.
  • 9Roncador G, Brown P J, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4^+ CD25^+ regulatory T cells at the single-cell level[ J ]. Eur J Immunol,2005,35 (6) : 1681 - 1691.
  • 10Bach J F. Regulatory T cells under scrutiny[ J]. Nat Rev Immunol, 2003,3(3) :189 - 198.

共引文献12

同被引文献35

  • 1Morrison CD, Parvani JG, Sehiemann WP. The relevance of the TGF-β paradox to EMT-MET programs [ J ]. Cancer Lett, 2013, Mar 5. [ Epub ahead of print].
  • 2Hader C, Marlier A, Cantley L. Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2 [J]. Oncogene , 2010, 29(7) : 1031-1040.
  • 3Wang Y, Lui WY. Transforming growth factor-β1 attenu- ates junctional adhesion molecule-A and contributes to breast cancer cell invasion [ J]. Eur J Cancer, 2012,48 (18) :3475-3487.
  • 4Mani SA, Yang J, Brooks M, et al. Mesenchyme Fork- head 1 (FOXC2) plays a key role in metastasis and is as- sociated with aggressive basal-like breast cancers [ J ]. PNAS, 2007, 104(24): 10069-10074.
  • 5Zagouri F, Bago-Horvath Z, Rossler F, et al. High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer[ J]. Br J Cancer, 2013,108 (5) :1100-1105.
  • 6Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mes- enehymal composition [ J ]. Science, 2013, 339 ( 6119 ) : 580-584.
  • 7Yao D, Dai C, Peng S. Mechanism of the mesenchymal- epithelial transition and its relationship with metastatic tumor formation [ J ]. Mol Cancer Res, 2011, 9 ( 12 ) : 1608-1620.
  • 8Ono Y, Hayashida T, Konagai A, et al. Direct inhibition of the transforming growth factor-13 pathway by protein- bound polysaccharide through inactivation of Smad2 signa- ling[ J]. Cancer Sci, 2013,32(12) : 1549-1559.
  • 9Freudlsperger C, Bian Y, Contag Wise S, et al. TGF-t3 and NF-KB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers [ J ]. Oncogene, 2013,32 (12) : 1549-1559.
  • 10Taube JH, Herschkowitz JI, Komurov K, et al. Core epi- thelial-to-mesenchymal transition interactome gene-expres- sion signature is associated with claudin-low and metaplas- tic breast cancer subtypes [ J ]. Proc Natl Acad Sci U S A, 2010,107 (35) : 15449-15454.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部